Biotest
BIO.F
$75.23
Share price
0.48%
Change (1 day)
11.41%
Change (1 year)
Categories
Revenue for Biotest (BIO.F)
Revenue in 2024 (TTM): A$1.15 Billion
According to Biotest
's latest financial reports the company's current revenue (TTM 
) is A$1.26 Billion. In 2023 the company made a revenue of A$1.08 Billion an increase over the revenue in the year 2022 that were of A$0.80 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Biotest from 2009 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | A$1.15 B | 5.68% |
| 2023 | A$1.08 B | 35.85% |
| 2022 | A$0.80 B | -3.17% |
| 2021 | A$0.82 B | 13.04% |
| 2020 | A$0.73 B | 9.18% |
| 2019 | A$0.67 B | 0.37% |
| 2018 | A$0.66 B | 74.25% |
| 2017 | A$0.38 B | -51.28% |
| 2016 | A$0.78 B | -12.05% |
| 2015 | A$0.89 B | -3.18% |
| 2014 | A$0.92 B | 23.72% |
| 2013 | A$0.74 B | 35.44% |
| 2012 | A$0.55 B | -2.87% |
| 2011 | A$0.56 B | 16.44% |
| 2010 | A$0.48 B | -29.3% |
| 2009 | A$0.68 B |